StockData
MacroGenics Inc logo

MacroGenics Inc (MGNX) stock

MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.97−0.08 (-3.90%)

Close on Nov 18, 2026Market cap $125.49MP/E –Yield –

MacroGenics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

MacroGenics's revenue for the twelve months ending Jun 30, 2026 was $167.67M, up 11.7% year over year. For fiscal 2025 it was $149.50M, down 0.3% from the year before. Over ten years it grew 4.0% a year on average. The highest annual figure on record is $157.74M in fiscal 2017.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$149.50M-0.3%
FY2024Dec 31, 2024$149.96M+155.3%
FY2023Dec 31, 2023$58.75M-61.3%
FY2022Dec 31, 2022$151.94M+96.2%
FY2021Dec 31, 2021$77.45M-26.2%
FY2020Dec 31, 2020$104.88M+63.4%
FY2019Dec 31, 2019$64.19M+6.8%
FY2018Dec 31, 2018$60.12M-61.9%
FY2017Dec 31, 2017$157.74M+71.7%
FY2016Dec 31, 2016$91.88M-8.9%
FY2015Dec 31, 2015$100.85M+111.0%
FY2014Dec 31, 2014$47.80M-17.6%
FY2013Dec 31, 2013$58.04M-9.1%
FY2012Dec 31, 2012$63.83M+11.6%
FY2011Dec 31, 2011$57.21M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$32.83M+378.0%
Q1 FY2026Mar 31, 2026$20.78M+57.5%
Q4 FY2025Dec 31, 2025$41.23M+113.0%
Q3 FY2025Sep 30, 2025$72.84M-34.2%
Q2 FY2025Jun 30, 2025$6.87M-36.4%
Q1 FY2025Mar 31, 2025$13.19M+44.9%
Q4 FY2024Dec 31, 2024$19.35M+80.5%
Q3 FY2024Sep 30, 2024$110.71M+964.8%
Q2 FY2024Jun 30, 2024$10.80M-17.8%
Q1 FY2024Mar 31, 2024$9.10M-62.8%
Q4 FY2023Dec 31, 2023$10.72M-85.3%
Q3 FY2023Sep 30, 2023$10.40M-75.1%
Q2 FY2023Jun 30, 2023$13.14M-49.5%
Q1 FY2023Mar 31, 2023$24.50M+120.7%
Q4 FY2022Dec 31, 2022$73.10M+416.7%
Q3 FY2022Sep 30, 2022$41.73M+166.5%
Q2 FY2022Jun 30, 2022$26.01M-15.4%
Q1 FY2022Mar 31, 2022$11.10M-34.2%
Q4 FY2021Dec 31, 2021$14.15M-73.2%
Q3 FY2021Sep 30, 2021$15.66M-14.2%
Q2 FY2021Jun 30, 2021$30.76M+51.8%
Q1 FY2021Mar 31, 2021$16.88M+23.4%
Q4 FY2020Dec 31, 2020$52.69M+109.2%
Q3 FY2020Sep 30, 2020$18.25M-2.6%
Q2 FY2020Jun 30, 2020$20.26M+91.2%
Q1 FY2020Mar 31, 2020$13.68M+41.6%
Q4 FY2019Dec 31, 2019$25.19M+59.5%
Q3 FY2019Sep 30, 2019$18.74M-9.9%
Q2 FY2019Jun 30, 2019$10.59M-43.8%
Q1 FY2019Mar 31, 2019$9.66M+105.8%
Q4 FY2018Dec 31, 2018$15.79M-89.6%
Q3 FY2018Sep 30, 2018$20.80M+1150.6%
Q2 FY2018Jun 30, 2018$18.83M+1030.5%
Q1 FY2018Mar 31, 2018$4.70M+128.5%
Q4 FY2017Dec 31, 2017$152.36M+2883.9%
Q3 FY2017Sep 30, 2017$1.66M-48.9%
Q2 FY2017Jun 30, 2017$1.67M–
Q1 FY2017Mar 31, 2017$2.06M–
Q4 FY2016Dec 31, 2016$5.11M–
Q3 FY2016Sep 30, 2016$3.26M–

More MacroGenics figures

See a number that looks wrong?